

Cover Story
This was not your ordinary ODAC, but a three-day checkpoint inhibitor marathon that consumed April 27, 28, and 29. You might call it six ODACs for the price of one: subtle as all get-out, if-you-blink-you-miss-it head-spinner of a shindig.
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Betty Ford and the press conference that changed oncology
- Bipartisan misgivings: House appropriators chafe at Biden’s proposal to fund ARPA-H at the expense of NIH
- Robert Winn, Rebecca Miksad, Dana Rollison: We must use real-world data and lessons from COVID to improve care, equity in communities we serve
- Cancer is complex and dynamic—ergo, dose optimization calls for mathematical modeling
- Chernobyl: a 35 year follow up on long-term health effects
- Equity and action: Ida Spruill and Walter Lawrence